Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1994-1-26
pubmed:abstractText
Squamous epithelial cancer in situ (CIS) of the upper aerodigastric tract is a histopathologically well-defined condition. However, in clinical practice, morphological grading of dysplasia is difficult and shows large variability. The biology of CIS remains enigmatic, and there is yet no reliable way to predict whether a CIS lesion will progress to invasive cancer, remain stable or regress. In the search for markers able to foretell clinical outcome, we performed image DNA cytometry (ICM) and immunohistochemical staining for PCNA as well as p53 in 38 laryngeal CIS lesions, of which 9 progressed to invasive cancer. The majority of the CIS lesions displayed high-grade DNA aberration, a high PCNA-positive rate, and every third lesion was p53-positive by immunostaining. The lesions which progressed to invasive cancer showed a clear tendency towards more pronounced DNA aberration, a higher percentage of intense PCNA staining and more frequent p53 positivity. By combining the results from the analyses of DNA, PCNA and p53 in a prognostic index for each individual case, we correctly classified 82% of the lesions as progressors or non-progressors.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0020-7136
pubmed:author
pubmed:issnType
Print
pubmed:day
2
pubmed:volume
56
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
95-9
pubmed:dateRevised
2007-7-24
pubmed:meshHeading
pubmed-meshheading:7903288-Adult, pubmed-meshheading:7903288-Aged, pubmed-meshheading:7903288-Aged, 80 and over, pubmed-meshheading:7903288-Antigens, Neoplasm, pubmed-meshheading:7903288-Carcinoma, Squamous Cell, pubmed-meshheading:7903288-Carcinoma in Situ, pubmed-meshheading:7903288-Cell Nucleus, pubmed-meshheading:7903288-DNA, Neoplasm, pubmed-meshheading:7903288-Discriminant Analysis, pubmed-meshheading:7903288-Female, pubmed-meshheading:7903288-Humans, pubmed-meshheading:7903288-Immunohistochemistry, pubmed-meshheading:7903288-Laryngeal Neoplasms, pubmed-meshheading:7903288-Male, pubmed-meshheading:7903288-Middle Aged, pubmed-meshheading:7903288-Nuclear Proteins, pubmed-meshheading:7903288-Prognosis, pubmed-meshheading:7903288-Proliferating Cell Nuclear Antigen, pubmed-meshheading:7903288-Tumor Markers, Biological, pubmed-meshheading:7903288-Tumor Suppressor Protein p53
pubmed:year
1994
pubmed:articleTitle
Nuclear DNA content, proliferating-cell nuclear antigen (PCNA) and p53 immunostaining in predicting progression of laryngeal cancer in situ lesions.
pubmed:affiliation
Department of Oto-rhino-laryngology, Karolinska Hospital, Stockholm, Sweden.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't